Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion type Assertion NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_head.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion wasGeneratedBy ECO_0000203 NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_provenance.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion wasDerivedFrom befree-20150227 NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_provenance.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion SIO_000772 21695374 NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_provenance.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion evidence source_evidence_literature NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_provenance.
- NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_assertion description "[We found statistically significant association of polymorphisms rs1050152 in gene SLC22A4 (p = 0.005, OR = 2.177, 95% CI = 1.270-3.526) and rs2631372 in gene SLC22A5 (p = 0.001, OR = 0.473, 95% CI = 0.307-0.731) and TC haplotype of both polymorphisms (p = 0.006, OR = 1,541, 95% CI = 1.130-2.100) with refractory Crohn's disease (CD) in Slovenian patients who do not respond to standard therapy, including patients who develop fistulas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701917.RALZ63S9eD3AVPFIiq9_jRkt8V4k4wYkwYVNCsGP_PRSM130_provenance.